Author name: TB Alliance

An array of well-heeled new players has dramatically reshaped how wealthy countries tackle infectious diseases of the poor. But increasingly,

On October 17, 2005, at the TB Alliance’s Annual Stakeholders Association Meeting in Paris, members approved the addition of four

On October 23rd, at the 36th World Congress on Lung Health in Paris, a group of individuals and organizations from

From November 1-3, Time Magazine convened leaders in medicine, government, business and public policy to discuss critical issues concerning global

The TB Alliance and the Korean Research Institute of Chemical Technology (KRICT) recently renewed their Agreement to develop novel quinolone

On November 2, 2005, at the Time Summit, Dr. Maria C. Freire, President & CEO of the TB Alliance participated

My pregnant 25-year-old patient was understandably concerned when her tuberculosis (TB) skin test came back positive. Her brother had died

PARIS–The amount of time required to treat tuberculosis (TB) could be halved if a series of phase II clinical trials

Bayer has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone antibiotic, moxifloxacin,